The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
β 2 -Adrenoceptor Polymorphism Determines Vascular Reactivity in Humans
Abstract
Abstract —Altered β-adrenergic regulation has been reported in individuals with hypertension. The variability in vascular responsiveness to β-agonists, such as isoproterenol, observed in humans may be explained partially by β 2 -adrenoceptor polymorphism. Individuals with the Gln27 form of the receptor may show reduced vascular reactivity because of downregulation expression of the receptor in the vasculature. We screened 127 normotensive white subjects, 37 of whom were homozygous for these alleles. Thirty-two subjects (17 Gln27 and 15 Glu27) agreed to receive brachial artery infusions of isoproterenol at doses of 1 to 300 ng · min − 1 ; forearm blood flow was measured by using venous occlusion plethysmography. Of these subjects, 25 (12 Glu27 and 13 Gln27) received local doses of isoproterenol (0.3 to 30.0 ng · min − 1 ) via a dorsal hand vein preconstricted with norepinephrine. Compared with subjects homozygous for the Glu27 allele, subjects with the Gln27 substitution had lower baseline blood flow and, in response to isoproterenol, had a significantly attenuated increase in forearm blood flow. This pattern was more marked in veins. We also studied the relationship between the position 16 polymorphism and vascular reactivity. Homozygotes for Arg16 had significantly lower basal blood flow and attenuated increases in forearm blood flow compared with the Gly16 homozygotes. This was significant in veins but not in arteries. Thus, β 2 -adrenoceptor genotype determines vascular responses to isoproterenol in forearm resistance vessels and in capacitance vessels. Further studies are necessary to establish whether β 2 -adrenoceptor polymorphisms are important in the genesis of hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term exposure to β2-receptor agonist specifically desensitizes β-receptor—mediated venodilation
Stein, M., Deegan, R., & Wood, A. J. J. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.130 · Cited by 29
Cited by
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Nabel, E. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035098 · Cited by 431
Pharmacogenomics: The Inherited Basis for Interindividual Differences in Drug Response
Evans, W. E., & Johnson, J. A. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.9 · Cited by 415
Anaphylaxis: Lessons from mouse models
Finkelman, F. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.033 · Cited by 404
Dishy, V., Sofowora, G. G., Xie, H.-G., Kim, R. B., Byrne, D. W., Stein, C. M., & Wood, A. J. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010819 · Cited by 363
Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications
Wilkinson, I. B., & Webb, D. J. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01495.x · Cited by 355
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice
Heximer, S. P., Knutsen, R. H., Sun, X., Kaltenbronn, K. M., Rhee, M.-H., Peng, N., Oliveira-dos-Santos, A., Penninger, J. M., Muslin, A. J., Steinberg, T. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15598 · Cited by 334
Pharmacology and physiology of human adrenergic receptor polymorphisms
Small, K. M., McGraw, D. W., & Liggett, S. B. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135823 · Cited by 323
Metadata
- Authors
- Cockcroft, J. R., Gazis, A. G., Cross, D. J., Wheatley, A., Dewar, J., Hall, I. P., & Noon, J. P.
- Venue
- Hypertension
- Published
- 2000-09
- Volume
- 36
- Issue
- 3
- Pages
- 371-375
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2013162676
- Cited by
- 160
- References
- 1
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.